Cytosorbents EBITDA Margin 2010-2025 | CTSO
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Cytosorbents (CTSO) over the last 10 years. The current EBITDA margin for Cytosorbents as of June 30, 2025 is .
| Cytosorbents EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2025-06-30 | $0.04B | $-0.01B | -38.89% |
| 2025-03-31 | $0.04B | $-0.01B | -40.00% |
| 2024-12-31 | $0.04B | $-0.02B | -42.86% |
| 2024-09-30 | $0.03B | $-0.02B | -66.67% |
| 2024-06-30 | $0.03B | $-0.02B | -76.67% |
| 2024-03-31 | $0.03B | $-0.03B | -86.67% |
| 2023-12-31 | $0.03B | $-0.03B | -100.00% |
| 2023-09-30 | $0.04B | $-0.03B | -75.00% |
| 2023-06-30 | $0.04B | $-0.03B | -82.86% |
| 2023-03-31 | $0.03B | $-0.03B | -91.18% |
| 2022-12-31 | $0.03B | $-0.03B | -91.18% |
| 2022-09-30 | $0.04B | $-0.03B | -94.44% |
| 2022-06-30 | $0.04B | $-0.03B | -78.95% |
| 2022-03-31 | $0.04B | $-0.03B | -64.29% |
| 2021-12-31 | $0.04B | $-0.02B | -50.00% |
| 2021-09-30 | $0.05B | $-0.02B | -33.33% |
| 2021-06-30 | $0.05B | $-0.01B | -26.09% |
| 2021-03-31 | $0.04B | $-0.01B | -22.73% |
| 2020-12-31 | $0.04B | $-0.01B | -21.43% |
| 2020-09-30 | $0.04B | $-0.01B | -32.43% |
| 2020-06-30 | $0.03B | $-0.02B | -46.88% |
| 2020-03-31 | $0.03B | $-0.02B | -53.57% |
| 2019-12-31 | $0.02B | $-0.02B | -70.83% |
| 2019-09-30 | $0.02B | $-0.02B | -73.91% |
| 2019-06-30 | $0.02B | $-0.02B | -65.22% |
| 2019-03-31 | $0.02B | $-0.02B | -69.57% |
| 2018-12-31 | $0.02B | $-0.02B | -65.22% |
| 2018-09-30 | $0.02B | $-0.01B | -63.64% |
| 2018-06-30 | $0.02B | $-0.01B | -65.00% |
| 2018-03-31 | $0.02B | $-0.01B | -61.11% |
| 2017-12-31 | $0.02B | $-0.01B | -56.25% |
| 2017-09-30 | $0.01B | $-0.01B | -71.43% |
| 2017-06-30 | $0.01B | $-0.01B | -83.33% |
| 2017-03-31 | $0.01B | $-0.01B | -110.00% |
| 2016-12-31 | $0.01B | $-0.01B | -133.33% |
| 2016-09-30 | $0.01B | $-0.01B | -125.00% |
| 2016-06-30 | $0.01B | $-0.01B | -142.86% |
| 2016-03-31 | $0.01B | $-0.01B | -150.00% |
| 2015-12-31 | $0.01B | $-0.01B | -180.00% |
| 2015-09-30 | $0.00B | $-0.01B | -225.00% |
| 2015-06-30 | $0.00B | $-0.01B | -200.00% |
| 2015-03-31 | $0.00B | $-0.01B | -175.00% |
| 2014-12-31 | $0.00B | $-0.01B | -150.00% |
| 2014-09-30 | $0.00B | $0.00B | -100.00% |
| 2014-06-30 | $0.00B | $0.00B | -100.00% |
| 2014-03-31 | $0.00B | $0.00B | -133.33% |
| 2013-12-31 | $0.00B | $0.00B | -200.00% |
| 2013-09-30 | $0.00B | $0.00B | -200.00% |
| 2013-06-30 | $0.00B | $0.00B | -200.00% |
| 2013-03-31 | $0.00B | $0.00B | -200.00% |
| 2012-12-31 | $0.00B | $0.00B | -200.00% |
| 2012-09-30 | $0.00B | $0.00B | -400.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.059B | $0.036B |
| CytoSorbents Corporation is a therapeutic medical device company. It develops adsorbent polymer technology for applications in the medical field, primarily to provide blood purification for the treatment of acute and chronic health complications associated with blood toxicity. The Company's product include CytoSorb, which filters cytokines and treat potentially fatal cytokine storm and BetaSorb, which remove beta2-microglobulin from the blood of patients suffering from chronic kidney failure. CytoSorbents Corporation is headquartered in Monmouth Junction, New Jersey. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $228.644B | 26.81 |
| Boston Scientific (BSX) | United States | $156.695B | 37.37 |
| Stryker (SYK) | United States | $148.974B | 30.33 |
| EssilorLuxottica (ESLOY) | France | $142.491B | 0.00 |
| Medtronic (MDT) | Ireland | $117.956B | 16.63 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.926B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.457B | 24.85 |
| ResMed (RMD) | United States | $40.320B | 28.84 |
| Agilent Technologies (A) | United States | $35.497B | 22.93 |
| GE HealthCare Technologies (GEHC) | United States | $33.658B | 15.82 |
| Terumo (TRUMY) | Japan | $26.798B | 31.75 |
| Koninklijke Philips (PHG) | Netherlands | $26.557B | 17.57 |
| Insulet (PODD) | United States | $23.765B | 79.62 |
| Zimmer Biomet Holdings (ZBH) | United States | $20.812B | 13.25 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $16.306B | 0.00 |
| Baxter (BAX) | United States | $12.532B | 9.68 |
| Sunny Optical Technology (SNPTF) | China | $10.800B | 0.00 |
| Demant (WILYY) | Denmark | $8.121B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.947B | 29.19 |
| Lantheus Holdings (LNTH) | United States | $3.774B | 10.20 |
| Envista Holdings (NVST) | United States | $3.531B | 24.71 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.310B | 14.69 |
| Perrigo (PRGO) | Ireland | $3.269B | 8.16 |
| ICU Medical (ICUI) | United States | $3.136B | 21.35 |
| Haemonetics (HAE) | United States | $2.618B | 11.69 |
| Curaleaf Holdings (CURLF) | Canada | $2.259B | 0.00 |
| Acuren (TIC) | United States | $2.215B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $2.157B | 46.25 |
| QuidelOrtho (QDEL) | United States | $1.901B | 11.97 |
| Green Thumb Industries (GTBIF) | United States | $1.865B | 80.09 |
| AtriCure (ATRC) | United States | $1.850B | 0.00 |
| Tilray Brands (TLRY) | Canada | $1.618B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.559B | 18.40 |
| AdaptHealth (AHCO) | United States | $1.250B | 17.77 |
| Neogen (NEOG) | United States | $1.249B | 19.83 |
| BioLife Solutions (BLFS) | United States | $1.194B | 2492.00 |
| InMode (INMD) | Israel | $0.943B | 8.73 |
| Kestra Medical Technologies (KMTS) | United States | $0.909B | 0.00 |
| Valneva SE (VALN) | France | $0.752B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.727B | 0.00 |
| SNDL (SNDL) | Canada | $0.707B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.608B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.597B | 0.00 |
| ZimVie (ZIMV) | United States | $0.533B | 20.54 |
| Surmodics (SRDX) | United States | $0.491B | 0.00 |
| Evolus (EOLS) | United States | $0.486B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.476B | 16.39 |
| Canopy Growth (CGC) | Canada | $0.451B | 0.00 |
| CeriBell (CBLL) | United States | $0.439B | 0.00 |
| Owens & Minor (OMI) | United States | $0.383B | 3.40 |
| Sanuwave Health (SNWV) | United States | $0.364B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.343B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.317B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.300B | 0.00 |
| Brainsway (BWAY) | Israel | $0.290B | 59.00 |
| High Tide (HITI) | Canada | $0.290B | 0.00 |
| Omeros (OMER) | United States | $0.288B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.286B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.280B | 21.26 |
| TriSalus Life Sciences (TLSI) | United States | $0.255B | 0.00 |
| Cerus (CERS) | United States | $0.251B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.241B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.238B | 0.00 |
| Organigram Global (OGI) | Canada | $0.232B | 0.00 |
| Exagen (XGN) | United States | $0.214B | 0.00 |
| Quanterix (QTRX) | United States | $0.211B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.199B | 16.59 |
| FitLife Brands (FTLF) | United States | $0.175B | 21.60 |
| Biote (BTMD) | United States | $0.172B | 5.69 |
| Jushi Holdings (JUSHF) | United States | $0.147B | 0.00 |
| Jin Medical (ZJYL) | China | $0.124B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.114B | 0.00 |
| MacroGenics (MGNX) | United States | $0.107B | 0.00 |
| Fonar (FONR) | United States | $0.099B | 12.70 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.090B | 0.00 |
| Apyx Medical (APYX) | United States | $0.076B | 0.00 |
| Agape ATP (ATPC) | $0.067B | 0.00 | |
| Rockwell Medical (RMTI) | United States | $0.062B | 0.00 |
| Safety Shot (SHOT) | United States | $0.058B | 0.00 |
| ImmuCell (ICCC) | United States | $0.055B | 32.21 |
| MariMed (MRMD) | United States | $0.054B | 0.00 |
| Zynex (ZYXI) | United States | $0.050B | 0.00 |
| Veru (VERU) | United States | $0.049B | 0.00 |
| Nephros (NEPH) | United States | $0.043B | 33.58 |
| Modular Medical (MODD) | United States | $0.041B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 14.34 |
| Senestech (SNES) | United States | $0.024B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Allurion Technologies (ALUR) | United States | $0.017B | 0.00 |
| Sharps Technology (STSS) | United States | $0.016B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.015B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.013B | 0.00 |
| Flora Growth (FLGC) | United States | $0.012B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |